89bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
89bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • 89bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $108M, a 42.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $108M +$32.2M +42.4% Dec 31, 2023 10-K 2024-03-01
Q4 2022 $76M +$33.9M +80.7% Dec 31, 2022 10-K 2024-03-01
Q4 2021 $42M +$20.1M +91.7% Dec 31, 2021 10-K 2023-03-15
Q4 2020 $21.9M +$11.9M +119% Dec 31, 2020 10-K 2022-03-24
Q4 2019 $10M +$6.52M +186% Dec 31, 2019 10-K 2021-03-25
Q4 2018 $3.5M Dec 31, 2018 10-K 2020-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.